- Research works
- 84 ▲ 34% vs 2013–17
- Citations
- 1.2k 14.0 per fractional work
- Top-10% rate
- 12.0% record average 16.5%
- Open access
- 41% world 28%
Not ranked overall: Janssen (Italy) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 6.3×. Every wedge is a field page.
- Economics, Econometrics and Finance 6.3×
- Immunology and Microbiology 5.4×
- Medicine 2.1×
- Chemistry 1.7×
- Health Professions 1.7×
- Psychology 1.7×
- Biochemistry, Genetics and Molecular Biology 1.4×
- Veterinary 1.4×
- Decision Sciences 1.4×
- Neuroscience 1.3×
- Pharmacology, Toxicology and Pharmaceutics 1.3×
- Mathematics 0.9×
- Computer Science 0.7×
- Materials Science 0.6×
- Earth and Planetary Sciences 0.5×
- Nursing 0.5×
- Engineering 0.3×
- Environmental Science 0.2×
- Social Sciences 0.1×
- Agricultural and Biological Sciences 0.1×
- Business, Management and Accounting 0.0×
Which keywords describe research at Janssen (Italy)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Minimal Residual Disease, Diagnosis Criteria, International Myeloma Working Group, Economic Evaluation, Cost-effectiveness Analysis, Health Utility Measures, Quality of Life and Epidemiology.
- Immunogenicity
- Biosimilars
- Generic Drugs
- Inflammatory Bowel Disease
- Health Utility Measures
- Economic Evaluation
- International Myeloma Working Group
- Minimal Residual Disease
- Epidemiology
- Diagnosis Criteria
- Quality of Life
- Cost-effectiveness Analysis
- Crohn's Disease
- Drug Development Costs
- Clinical Trials
- Genetics
- Monoclonal Antibodies
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 17 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 17 words, with their numbers
- Epidemiology3▲ 2.8×17 topics
- Minimal Residual Disease2▲ 133×2 topics
- Diagnosis Criteria2▲ 254×1 topic
- International Myeloma Working Group2▲ 254×1 topic
- Quality of Life2▲ 5.8×8 topics
- Economic Evaluation2▲ 62×2 topics
- Cost-effectiveness Analysis2▲ 87×1 topic
- Health Utility Measures2▲ 87×1 topic
- Crohn's Disease1▲ 73×2 topics
- Inflammatory Bowel Disease1▲ 51×3 topics
- Drug Development Costs1▲ 205×1 topic
- Generic Drugs1▲ 205×1 topic
- Clinical Trials1▲ 7.1×5 topics
- Biosimilars1▲ 205×1 topic
- Genetics1▲ 5.9×4 topics
- Immunogenicity1▲ 95×1 topic
- Monoclonal Antibodies1▲ 47×2 topics
Which research topics does Janssen (Italy) publish most on?
By volume in 2022–2025: Multiple Myeloma Research and Treatments, Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy and Biosimilars and Bioanalytical Methods.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Multiple Myeloma Research and Treatments Hematology 2 works
- 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
- 3 Pharmaceutical Economics and Policy Economics and Econometrics 1 works
- 4 Biosimilars and Bioanalytical Methods Immunology 1 works
- 5 Inflammatory Bowel Disease Genetics 1 works
- 6 Rheumatoid Arthritis Research and Therapies Rheumatology 1 works
- 7 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
- 8 Mycobacterium research and diagnosis Epidemiology 0 works
- 9 Safe Handling of Antineoplastic Drugs Occupational Therapy 0 works
- 10 Microscopic Colitis Epidemiology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Janssen (Italy)'s research output changed?
Output in 2018–2022 was 34% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Cologno Monzese
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.